Anticancer effects of solasonine: Evidence and possible mechanisms

YingZheng Wang1, Tong Wang2, WeiDong Liu1

  • 1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China.

Insights

Solasonine, a key compound from Solanum nigrum L, effectively combats tumors by inhibiting cancer cell growth, promoting cell death, and preventing metastasis. This review explores its anti-cancer mechanisms for future therapeutic development.

Area of Science:

  • Pharmacology
  • Oncology
  • Traditional Chinese Medicine

Background:

  • Traditional Chinese Medicine (TCM) components show promise as anti-cancer agents.
  • Solasonine is identified as a primary active anti-tumor compound in Solanum nigrum L.

Purpose of the Study:

  • To summarize the anti-tumor mechanisms of solasonine.
  • To identify the molecular targets of solasonine in cancer treatment.
  • To provide a theoretical basis for solasonine's clinical application.

Main Methods:

  • Literature review of preclinical and clinical studies on solasonine.
  • Analysis of solasonine's effects on tumor cell proliferation, apoptosis, and metastasis.
  • Investigation into solasonine-induced ferroptosis in cancer cells.

Main Results:

  • Solasonine demonstrates significant inhibition of tumor cell proliferation.
  • Solasonine effectively induces apoptosis and ferroptosis in various cancer cell lines.
  • Solasonine has been shown to inhibit tumor cell metastasis, reducing cancer progression.

Conclusions:

  • Solasonine exhibits multifaceted anti-tumor properties.
  • Understanding solasonine's mechanisms and targets can guide the development of novel cancer therapies.
  • Further research into solasonine holds potential for advancing cancer treatment strategies.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K